Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 3,280 shares at $2.21 ($8K) on 2022-09-09, disclosed to the SEC on 2022-09-30.
Scheduled purchase ($8k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.35 | 110 | $259 | 3.2% |
| 2 | $2.31 | 110 | $254 | 3.2% |
| 3 | $2.23 | 110 | $245 | 3.1% |
| 4 | $2.35 | 110 | $259 | 3.2% |
| 5 | $2.51 | 110 | $276 | 3.5% |
| 6 | $2.59 | 110 |
| $285 |
| 3.6% |
| 7 | $2.59 | 110 | $285 | 3.6% |
| 8 | $2.62 | 110 | $288 | 3.6% |
| 9 | $2.55 | 110 | $281 | 3.5% |
| 10 | $2.44 | 115 | $281 | 3.5% |
| 11 | $2.38 | 115 | $274 | 3.4% |
| 12 | $2.36 | 115 | $271 | 3.4% |
| 13 | $2.39 | 115 | $275 | 3.4% |
| 14 | $2.42 | 115 | $278 | 3.5% |
| 15 | $2.15 | 115 | $247 | 3.1% |
| 16 | $2.24 | 115 | $258 | 3.2% |
| 17 | $2.22 | 115 | $255 | 3.2% |
| 18 | $2.21 | 60 | $133 | 1.7% |
| 19 | $2.46 | 115 | $283 | 3.5% |
| 20 | $2.45 | 115 | $282 | 3.5% |
| 21 | $2.51 | 115 | $289 | 3.6% |
| 22 | $2.47 | 115 | $284 | 3.6% |
| 23 | $2.49 | 115 | $286 | 3.6% |
| 24 | $2.56 | 105 | $269 | 3.4% |
| 25 | $2.54 | 105 | $267 | 3.3% |
| 26 | $2.59 | 105 | $272 | 3.4% |
| 27 | $2.51 | 105 | $264 | 3.3% |
| 28 | $2.55 | 105 | $268 | 3.3% |
| 29 | $2.49 | 105 | $261 | 3.3% |
| 30 | $2.57 | 105 | $270 | 3.4% |
| Total | $2.44 avg | 3,280 | $8K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |